Skip to main content

Table 3 The number (percentage) of randomised patients with usable data at the four time points

From: A pilot randomised controlled trial investigating a mindfulness-based stress reduction (MBSR) intervention in individuals with pulmonary arterial hypertension (PAH): the PATHWAYS study

Variable T1 (baseline) T2 (2–4 weeks) T3 (6 months) T4 (15 months)
Date of diagnosis 17 (50%) 23 (67.65%) 18 (52.94%) 7 (77.78%)
Diagnosis 32 (94.12%) 25 (73.53%) 21 (61.76%) 7 (77.78%)
Life expectancy from now 15 (44.12%) 8 (23.53%) 9 (26.47%) 1 (11.11%)
Date of last clinic visit 26 (76.47%) 23 (67.65%) 21 (61.76%) 6 (66.67%)
Current medication 32 (94.12%) 25 (73.53%) 21 (61.76%) 7 (77.78%)
Change in symptoms 31 (91.18%) 23 (67.65%) 16 (47.06%) 6 (66.67%)
What NYHA functional class is the patient now in 32 (94.12%) 24 (70.59%) 20 (58.82%) 7 (77.78%)
Number who changed to functional class since last visit 29 (85.29%) 23 (67.65%) 19 (55.88%) 6 (66.67%)
Patient’s medication has changed since last visit? 29 (85.29%) 25 (73.53%) 20 (58.82%) 7 (77.78%)
Change given (of those who changed medication) 4 (100%) 8 (88.89%) 9 (100%)  
Reasons given (of those who changed medication) 3 (75%) 8 (88.89%) 8 (88.89%)  
Opinion of whether patient is better, the same or worse 21 (61.76%) 19 (55.88%) 16 (47.06%) 4 (44.44%)
6-min walk 19 (55.8%) 12 (35.3%) 14 (41.1%) 4
Echocardiogram 19 (55.8%) 15 (44.1%) 13 (38.2%) 3
ECG 16 (47.1%) 14 (41.1%) 15 (44.1%) 4
SF-36 score
 SF-36 PCS 91.2% (31/34) 67.6% (23/34) 52.9% (18/34) 77.8% (7/9)
 SF-36 MCS 91.2% (31/34) 67.6% (23/34) 55.9% (19/34) 77.8% (7/9)
 SF-6D 88.2% (30/34) 67.6% (23/34) 52.9% (18/34) 66.7% (6/9)
 BAI 85.3% (29/34) 67.6% (23/34) 61.9% (21/34) 77.8% (7/9)
 BDI 91.2% (31/34) 67.6% (23/34) 58.8% (20/34) 77.8% (7/9)